Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNCL002384

Drug Information
CompanyAbbott Laboratories Abbott Park, IL
IndicationHematological malignancies (see also solid tumors)
[ICD9: 140-199, 140-239, 200-209, 210-229   ICD10: C00-C75, C00-C96, C7A, C7B, C81-C96, D10-D36, D3A]
Phase I    
Late-stage solid tumors (see also other)
[ICD9: 140-199, 210-229   ICD10: C00-C75, C7A, C7B, D10-D36, D3A]
Phase I    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1=CC(=CC(=C1)F)NC(=O)NC2=CC=C(C=C2)C3=CSC4=C3C(=NC=C4C5=CN(N=C5)CCO)N    
PubChem Compound IDCID 46207586.


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543